MondegarAI
Sessa Capital IM, L.P.

Q3 2025 · 13F-HR

Sessa Capital IM, L.P.holdings as filed

Filed 2025-11-14 · accession 0001398344-25-020983

$4.23B
Reported value
30
Positions
2025-09-30
Period end
View analyzed profile →PRO

The Brief · Sessa Capital IM, L.P. · Q3 2025

AI · grounded in 13F

Sessa Capital IM, L.P. established a new position in DUOL valued at $99.77M. The fund also initiated new stakes in KDP for $61.22M and PFGC for $31.02M. On the selling side, the fund closed its positions in GTX and GPC, reducing its exposure by $45.71M and $30.61M respectively.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
934423104WBDWARNER BROS DISCOVERY INC$988.7M23.4%50,624,148CommonSOLE
444859102HUMHUMANA INC$575.7M13.6%2,212,867CommonSOLE
452327109ILMNILLUMINA INC$445.1M10.5%4,686,779CommonSOLE
14040H105COFCAPITAL ONE FINL CORP$384.8M9.11%1,810,233CommonSOLE
69331C108PCGPG&E CORP$370.6M8.77%24,578,101CommonSOLE
009158106APDAIR PRODS & CHEMS INC$243.2M5.76%891,802CommonSOLE
02005N100ALLYALLY FINL INC$183.5M4.34%4,682,126CommonSOLE
83601L102SHCSOTERA HEALTH CO$156.0M3.69%9,919,619CommonSOLE
444859102HUMHUMANA INC$135.7M3.21%521,600CALLSOLE
26603R106DUOLDUOLINGO INC$99.8M2.36%310,000PUTSOLE
89469A104THSTREEHOUSE FOODS INC$84.9M2.01%4,200,000CommonSOLE
G3730V105FTAIFTAI AVIATION LTD$66.7M1.58%400,000CommonSOLE
989207105ZBRAZEBRA TECHNOLOGIES CORPORATI$61.5M1.46%206,984CommonSOLE
49271V100KDPKEURIG DR PEPPER INC$61.2M1.45%2,400,000CommonSOLE
875372203TNDMTANDEM DIABETES CARE INC$60.7M1.44%5,000,000CommonSOLE
912008109USFDUS FOODS HLDG CORP$59.9M1.42%781,295CommonSOLE
G3156P103ASAASA GOLD AND PRECIOUS MTLS L$48.1M1.14%1,050,000CommonSOLE
384747101GRALGRAIL INC$46.5M1.10%786,144CommonSOLE
77543R102ROKUROKU INC$35.0M0.83%350,000CommonSOLE
34965K107FTREFORTREA HLDGS INC$33.6M0.80%3,993,550CommonSOLE
71377A103PFGCPERFORMANCE FOOD GROUP CO$31.0M0.73%298,147CommonSOLE
60770K107MRNAMODERNA INC$19.2M0.45%743,081CommonSOLE
770323103RHIROBERT HALF INC.$10.2M0.24%300,000CALLSOLE
687793109OSCROSCAR HEALTH INC$9.5M0.22%500,000CommonSOLE
78397T202SABSSAB BIOTHERAPEUTICS INC$4.4M0.10%2,198,457CommonSOLE
00206R102TAT&T INC$4.1M0.10%143,886CommonSOLE
528872302LXRXLEXICON PHARMACEUTICALS INC$4.0M0.10%3,000,000CommonSOLE
05875B304BALYBALLYS CORPORATION$1.1M0.03%95,827CommonSOLE
649445400FLGFLAGSTAR FINANCIAL INC$370,9740.01%32,119CommonSOLE
10482B101BHRBRAEMAR HOTELS & RESORTS INC$70,8460.00%25,951CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.